SCHEDULE 13G: David J. Tweardy Discloses 7.0% Beneficial Ownership in TVARDI THERAPEUTICS, INC.
Beneficial Ownership Report
David J. Tweardy has reported a 7.0% beneficial ownership stake in TVARDI THERAPEUTICS, INC., comprising 652,398 shares of common stock.
Summary
- David J. Tweardy, a U.S. citizen, has filed a Schedule 13G indicating beneficial ownership of common stock in TVARDI THERAPEUTICS, INC.
- The filing reports an aggregate beneficial ownership of 652,398 shares of TVARDI THERAPEUTICS, INC. common stock.
- This ownership represents 7.0% of the company's outstanding common stock.
- The total beneficial ownership consists of 649,046 shares directly held by Mr. Tweardy and 3,352 shares issuable upon the exercise of stock options exercisable within 60 days.
- The percentage of class is calculated based on 9,355,542 shares of common stock outstanding as of April 15, 2025, as reported in the Issuer's Current Report on Form 8-K.
- Mr. Tweardy holds sole voting power and sole dispositive power over all 652,398 beneficially owned shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine disclosure of a significant beneficial ownership stake by an individual, which is a standard regulatory requirement for investors crossing certain ownership thresholds. It does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: Disclosure of a significant beneficial ownership stake by David J. Tweardy, representing 7.0% of the common stock, provides transparency regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of event which requires filing of this statement; also the date shares outstanding were reported in the Issuer's Form 8-K. |
| 05/02/2025 | Date of filing of this Schedule 13G statement. |
Keywords
TVARDI THERAPEUTICS, INC., David J. Tweardy, Schedule 13G, beneficial ownership, common stock, SEC filing, 140755208
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.